Contemporary Issues in Pharmaceutical Patent Law: Setting the Framework and Exploring Policy Options (Routledge Research in Intellectual Property) - Image 1

£141.05

Routledge Contemporary Issues in Pharmaceutical Patent Law: Setting the Framework and Exploring Policy Options (Routledge Research in Intellectual Property)

Name: Contemporary Issues in Pharmaceutical Patent Law: Setting the Framework and Exploring Policy Options (Routledge Research in Intellectual Property)
Brand: Routledge
Price: 141.05 GBP
Availability: InStock

Trade

This is the most expensive it has ever been. Walk away.

£141 today · previous high £141 · all-time low £140

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 48 days • 48 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 48 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £140 (43 days, 89.6%)

Price range: £140 - £141

Price levels: 2 different prices over 48 days

Description

This collection reflects on contemporary and contentious issues in international rulemaking in regards to pharmaceutical patent law. With chapters from both well-established and rising scholars, the collection contributes to the understanding of the regulatory framework governing pharmaceutical patents as an integrated discipline through the assessment of relevant laws, trends and policy options. Focusing on patent law and related pharmaceutical regulations, the collection addresses the pressing issues governments face in an attempt to resolve policy dilemmas involving competing interests, needs and objectives. The common theme running throughout the collection is the need for policy and law makers to think and act in a systemic manner and to be more reflective and responsive in finding new solutions within and outside the patent system to the long-standing problems as well as emerging challenges Review 'The editors have mustered a wide range of authors, including legal practitioners, academics and a Constitutional Court Justice, to opine on a broad range of topical issues confronting rule-makers concerning pharmaceutical patent law. This diversity makes for a varied discussion.' John A. Tessensohn, European Intellectual Property Review 'A solid reference book for scholars and those interested in governments’ struggle between incentivising innovation and access to affordable medicine.' John A. Tessensohn, European Intellectual Property Review About the Author Bryan Mercurio is Professor and Vice Chancellor's Outstanding Fellow of the Faculty of Law at the Chinese University of Hong Kong. Daria Kim is Doktorandin at the Max Planck Institute for Innovation and Competition.

Product Specifications

Brand: Routledge
Format: hardcover
ASIN: 1138934488
Category: Books > Subjects > Business, Finance & Law > Economics > International Economics > Trade
Domain: Amazon UK
Release Date: 15 December 2016
Listed Since: 27 June 2015

Barcode

No barcode data available

Routledge Contemporary Issues in Pharmaceutical Patent Law: Setting the Framework and Exploring Policy Options (Routledge Research in Intellectual Property)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Drugs, Patents and Policy: A Contextual Study of Hong Kong

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Patent Protection for Second Medical Uses (Aippi Law)

Routledge Intellectual Property and Access to Medicines in Africa

Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Intellectual Property in the Life Sciences: A Global Guide to Rights and Their Applications, Second Edition

Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries (Routledge Research in Health Law)

Oxford University Press - Balancing Wealth and Health Book

Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health

Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health? (Palgrave Studies in Public Health Policy Research)

Patent Rights in Pharmaceuticals in Developing Countries: Major Challenges for the Future

Research Handbook on Intellectual Property and the Life Sciences

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Patents, Human Rights, and Access to Medicines: The Role of States and Pharmaceutical Corporations

Guide to EU Pharmaceutical Regulatory Law

Intellectual Property Rights And The Life Science Industries: Past, Present And Future (2Nd Edition)

Medicines, Medical Devices and the Law

Collaborative Innovation in Drug Discovery: Strategies for Public and Private Partnerships (Wiley Series on Technologies for the Pharmaceutical Industry)

Medicines, Medical Devices and the Law